Product Images Fosamax

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Fosamax NDC 54868-4462 by Physicians Total Care, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image of 10 mg package label - 10mg package label

image of 10 mg package label - 10mg package label

This is a label of Fosamar 104g Tablets, distributed by Physicians Total Care with NDC number 54868-3857-0. It also includes the lot number, but the expiration date is not clear. The rest of the text seems to be either a barcode or product code and cannot be used for description.*

image of 35 mg package label - 35mg package label

image of 35 mg package label - 35mg package label

This is a product label. The product is distributed by Physicians Total Care and the lot number is 0680 with an expiration date of 6160. The rest of the information is not readable.*

image of 5 mg package label - 5mg package label

image of 5 mg package label - 5mg package label

This is a medication information label. The medication name is Fosare G, and it was distributed by Physicians Total Care. The NDC (National Drug Code) number is 54868-4384-0. The lot number is Yt ED, IE 010. The purpose or indication of the medication is not available, and neither are the directions for use or any further details.*

image of 70 mg package label - 70mg package label

image of 70 mg package label - 70mg package label

This is a package of medication containing Fosnark 76mg that is distributed by Physicians Total Care. The medication has an expiration date of 01780 and the package identification number is 44620040000.*

image of chemical structure - chemical structure

image of chemical structure - chemical structure

image of figure 1(Osteoporosis Treatment Studies in Postmenopausal Women) - figure 1

image of figure 1(Osteoporosis Treatment Studies in Postmenopausal Women) - figure 1

image of figure 2(Osteoporosis Treatment Studies in Postmenopausal Women) - figure 2

image of figure 2(Osteoporosis Treatment Studies in Postmenopausal Women) - figure 2

image of figure 3 (Cumulative Incidence of Hip Fractures) - figure 3

image of figure 3 (Cumulative Incidence of Hip Fractures) - figure 3

image of figure 4 (Osteoporosis Prevention Studies) - figure 4

image of figure 4 (Osteoporosis Prevention Studies) - figure 4

image of figure 5 (Studies in Glucocorticoid-Treated Patients) - figure 5

image of figure 5 (Studies in Glucocorticoid-Treated Patients) - figure 5

image of figure 6 (Studies in Paget's Disease of Bone) - figure 6

image of figure 6 (Studies in Paget's Disease of Bone) - figure 6

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.